RecruitingNCT06218030
L-methylfolate added to usual care for treatment-resistant generalized anxiety
About this title
Read the official source — NCT06218030Medication studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- KingstonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 22, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Queen's University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06218030
- Official title
Show the full official title
PSIY-744-23: Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Kingston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Queen's University, a university.
Does this study involve medication?
Yes. The study involves medication, including L-methylfolate.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
